Truncated somatostatin receptor 5 may modulate therapy response to somatostatin analogues — Observations in two patients with acromegaly and severe headache

A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease

Annamaria Colao, Stephan Petersenn, John Newell‐Price et al. · New England Journal of Medicine · 2012 · 641 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study

Annamaria Colao, Marcello D. Bronstein, Pamela U. Freda et al. · The Journal of Clinical Endocrinology & Metabolism · 2014 · 394 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line<i>AIP</i>Mutations and Pituitary Adenomas: An International Collaborative Study

Adrian Daly, María A. Tichomirowa, Patrick Pétrossians et al. · The Journal of Clinical Endocrinology & Metabolism · 2010 · 370 citations · Full text

Medicine, Endocrinology, Genetics +17

The clinical characteristics of headache in patients with pituitary tumours

Miles Levy, Manjit Matharu, Karim Meeran et al. · Brain · 2005 · 306 citations

Medicine, Endocrinology, Neurology +17

Safety and efficacy of long-term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients--a clinical research center study.

Connie B. Newman, Peter J. Snyder, William F. Young et al. · The Journal of Clinical Endocrinology & Metabolism · 1995 · 247 citations

Pharmacy, Endocrinology, Pharmacotherapy +16